<DOC>
	<DOC>NCT01477879</DOC>
	<brief_summary>This study will compare efficacy of versabase gel with 20% sarracenia purpurea versus placebo applied every 3-4 hours to herpes lesions.</brief_summary>
	<brief_title>Hsv 1 and 2 Gowey Protocol Versus Placebo</brief_title>
	<detailed_description>Patients screened for hsv one or two. Patients with herpes given a 1/8 oz of gel. Researcher does not know which is active and which is placebo (placebo is actually just versabase gel). Patent applies gel to lesions every 3-4 hours. Returns to clinic on days 3, 5, and 14 for evaluation. Up to 50 patients may be enrolled.</detailed_description>
	<criteria>Hsv 1&amp;2 No active lesions</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>